Lexaria Bioscience Corp.
0.70
0.11 (19.25%)
At close: Jan 15, 2025, 2:20 PM
0.70
0.00%
After-hours Jan 15, 2025, 02:20 PM EST
undefined%
Bid 0.25
Market Cap 40.39M
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) 0
PE Ratio (ttm) n/a
Forward PE n/a
Analyst n/a
Ask n/a
Volume 3,352
Avg. Volume (20D) 0
Open 0.69
Previous Close 0.59
Day's Range 0.69 - 0.80
52-Week Range 0.69 - 0.80
Beta undefined

About LEXXW

Lexaria Bioscience Corp. operates as a biotechnology company. It develops and out-licenses its patented drug delivery technology, DehydraTECH, which combines lipophilic molecules or active pharmaceutical ingredients with specific long-chain fatty acids and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing while promoting healthier oral ingestion methods. The com...

Industry Biotechnology
Sector Healthcare
IPO Date n/a
Employees 5
Stock Exchange NASDAQ
Ticker Symbol LEXXW
No News article available yet